Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) Short Interest Down 88.9% in February

Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) was the target of a significant drop in short interest during the month of February. As of February 28th, there was short interest totalling 100 shares, a drop of 88.9% from the February 13th total of 900 shares. Based on an average trading volume of 2,400 shares, the short-interest ratio is currently 0.0 days.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Stock Performance

NASDAQ HROWM traded up $0.06 during midday trading on Wednesday, hitting $26.66. The company had a trading volume of 237 shares, compared to its average volume of 2,824. The firm has a fifty day simple moving average of $26.59 and a two-hundred day simple moving average of $26.44. Harrow Health, Inc. 11.875% Senior Notes due 2027 has a fifty-two week low of $25.30 and a fifty-two week high of $27.70.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Wednesday, January 15th were given a $0.7422 dividend. The ex-dividend date was Wednesday, January 15th. This represents a $2.97 annualized dividend and a yield of 11.14%.

About Harrow Health, Inc. 11.875% Senior Notes due 2027

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.